27501756|t|Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression
27501756|a|Recently, long noncoding RNAs (lncRNAs) have been identified as critical regulators in numerous types of cancers, including non-small cell lung cancer (NSCLC). X inactivate-specific transcript (XIST) has been found to be up-regulated and acts as an oncogene in gastric cancer and hepatocellular carcinoma, but little is known about its expression pattern, biological function and underlying mechanism in NSCLC. Here, we identified XIST as an oncogenic lncRNA by driving tumorigenesis in NSCLC. We found that XIST is over- expressed in NSCLC, and its increased level is associated with shorter survival and poorer prognosis. Knockdown of XIST impaired NSCLC cells proliferation, migration and invasion in vitro, and repressed the tumorigenicity of NSCLC cells in vivo. Mechanistically, RNA immune-precipitation (RIP) and RNA pull-down experiment demonstrated that XIST could simultaneously interact with EZH2 to suppress transcription of its potential target KLF2. Additionally, rescue experiments revealed that XIST 's oncogenic functions were partly depending on silencing KLF2 expression. Collectively, our findings expound how XIST over- expression endows an oncogenic function in NSCLC.
27501756	0	18	Long noncoding RNA	T114	C2982391
27501756	19	23	XIST	T114	C3273444
27501756	35	43	oncogene	T028	C0029016
27501756	47	73	non-small cell lung cancer	T191	C0007131
27501756	77	102	epigenetically repressing	T045	C3494434
27501756	103	107	KLF2	T116,T123	C1456423
27501756	108	118	expression	T045	C1171362
27501756	129	148	long noncoding RNAs	T114	C2982391
27501756	150	157	lncRNAs	T114	C2982391
27501756	169	179	identified	T080	C0205396
27501756	192	202	regulators	T028	C0017362
27501756	206	214	numerous	T081	C0439064
27501756	224	231	cancers	T191	C0006826
27501756	243	269	non-small cell lung cancer	T191	C0007131
27501756	271	276	NSCLC	T191	C0007131
27501756	279	311	X inactivate-specific transcript	T114	C3273444
27501756	313	317	XIST	T114	C3273444
27501756	340	352	up-regulated	T044	C0041904
27501756	368	376	oncogene	T028	C0029016
27501756	380	394	gastric cancer	T191	C0699791
27501756	399	423	hepatocellular carcinoma	T191	C2239176
27501756	455	465	expression	T045	C1171362
27501756	466	473	pattern	T082	C0449774
27501756	475	494	biological function	T038	C3714634
27501756	510	519	mechanism	T169	C0441712
27501756	523	528	NSCLC	T191	C0007131
27501756	539	549	identified	T080	C0205396
27501756	550	554	XIST	T114,T123	C1571617
27501756	561	570	oncogenic	T028	C0029016
27501756	571	577	lncRNA	T114	C2982391
27501756	589	602	tumorigenesis	T191	C0596263
27501756	606	611	NSCLC	T191	C0007131
27501756	627	631	XIST	T114,T123	C1571617
27501756	641	650	expressed	T045	C0040649
27501756	654	659	NSCLC	T191	C0007131
27501756	669	678	increased	T081	C0205217
27501756	679	684	level	T080	C0441889
27501756	688	703	associated with	T080	C0332281
27501756	704	720	shorter survival	T033	C1850775
27501756	725	741	poorer prognosis	T033	C0278252
27501756	743	752	Knockdown	T063	C2350567
27501756	756	760	XIST	T114,T123	C1571617
27501756	761	769	impaired	T169	C0221099
27501756	770	775	NSCLC	T191	C0007131
27501756	776	795	cells proliferation	T043	C0596290
27501756	797	806	migration	T043	C1622501
27501756	811	819	invasion	T046	C2699153
27501756	820	828	in vitro	T062	C0681828
27501756	848	862	tumorigenicity	T046	C1519697
27501756	866	871	NSCLC	T191	C0007131
27501756	878	885	in vivo	T062	C0681829
27501756	904	907	RNA	T114	C0035668
27501756	908	928	immune-precipitation	T059	C0021069
27501756	930	933	RIP	T059	C0021069
27501756	939	942	RNA	T114	C0035668
27501756	943	963	pull-down experiment	T062	C0681814
27501756	982	986	XIST	T114,T123	C1571617
27501756	1008	1016	interact	T169	C1704675
27501756	1022	1026	EZH2	T116,T123	C1172384
27501756	1030	1038	suppress	T169	C1260953
27501756	1039	1052	transcription	T045	C0040649
27501756	1060	1069	potential	T080	C3245505
27501756	1070	1076	target	T169	C1521840
27501756	1077	1081	KLF2	T116,T123	C1456423
27501756	1104	1115	experiments	T062	C0681814
27501756	1116	1124	revealed	T080	C0443289
27501756	1130	1134	XIST	T114,T123	C1571617
27501756	1138	1147	oncogenic	T028	C0029016
27501756	1148	1157	functions	T169	C0542341
27501756	1183	1192	silencing	T045	C0598496
27501756	1193	1197	KLF2	T116,T123	C1456423
27501756	1198	1208	expression	T045	C1171362
27501756	1228	1236	findings	T033	C0243095
27501756	1249	1253	XIST	T114,T123	C1571617
27501756	1260	1270	expression	T045	C0040649
27501756	1281	1290	oncogenic	T028	C0029016
27501756	1291	1299	function	T169	C0542341
27501756	1303	1308	NSCLC	T191	C0007131